Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125539601 | 12553960 | 1 | I | 20160701 | 20160713 | 20160713 | EXP | CA-HQ SPECIALTY-CA-2016INT000522 | INTERCHEM | 45.00 | YR | F | Y | 0.00000 | 20160713 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125539601 | 12553960 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 3.5714 MG (25 MG,1 IN 1 W) | 201749 | 25 | MG | ||||||||
| 125539601 | 12553960 | 2 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 400 MG (200 MG, 2 IN 1 D) | U | 0 | 200 | MG | |||||||
| 125539601 | 12553960 | 3 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG (20 MG, 1 IN 1 D) | U | 0 | 20 | MG | |||||||
| 125539601 | 12553960 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 2.8571 MG (40 MG, 1 IN 2 W) | Y | 0 | 40 | MG | |||||||
| 125539601 | 12553960 | 5 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | 100 MG EVERY MORNING AND 50 MG EVERY EVENING | 0 | ||||||||||
| 125539601 | 12553960 | 6 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1500 MG (500MG 3 TABS) TWICE A DAY, TOOK MORE THAN 6 MONTHS | Y | 0 | 500 | MG | |||||||
| 125539601 | 12553960 | 7 | C | NAPROSYN | NAPROXEN | 1 | Unknown | 1000 MG (500 MG, 2 IN 1 D) | U | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125539601 | 12553960 | 1 | Rheumatoid arthritis |
| 125539601 | 12553960 | 2 | Rheumatoid arthritis |
| 125539601 | 12553960 | 3 | Rheumatoid arthritis |
| 125539601 | 12553960 | 4 | Rheumatoid arthritis |
| 125539601 | 12553960 | 5 | Rheumatoid arthritis |
| 125539601 | 12553960 | 6 | Rheumatoid arthritis |
| 125539601 | 12553960 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125539601 | 12553960 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125539601 | 12553960 | Activities of daily living impaired | |
| 125539601 | 12553960 | Arthralgia | |
| 125539601 | 12553960 | Drug ineffective | |
| 125539601 | 12553960 | Musculoskeletal pain | |
| 125539601 | 12553960 | Musculoskeletal stiffness | |
| 125539601 | 12553960 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125539601 | 12553960 | 4 | 201202 | 0 |